✦ LIBER ✦

Impact of overweight and obesity on postmenopausal breast cancer: analysis of 20-year data from Switzerland

✍ Scribed by Monika Eichholzer; Seraina Margaretha Schmid; Florence Bovey; Paul Jordan; Sabine Rohrmann; Dorothy Jane Huang; Christoph Rochlitz; Uwe Güth

Book ID: 106081968
Publisher: Springer
Year: 2011
Tongue: English
Weight: 240 KB
Volume: 285
Category: Article
ISSN: 0003-9128
DOI: 10.1007/s00404-011-2022-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The impact of perinatal probiotic interv

The impact of perinatal probiotic intervention on the development of overweight and obesity: follow-up study from birth to 10 years

✍ Luoto, R; Kalliomäki, M; Laitinen, K; Isolauri, E 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 329 KB

Obesity Increases the Risk of Postmenopa

Obesity Increases the Risk of Postmenopausal Breast Cancer and is Associated with More Advanced Stage at Presentation But no Impact on Survival

✍ Laura A. Healy; Aoife M. Ryan; Suzanne Rowley; Terry Boyle; Elizabeth Connolly; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB

Survival of metastatic breast carcinoma

Survival of metastatic breast carcinoma patients over a 20-year period : A retrospective analysis based on individual patient data from six consecutive studies

✍ Alessandra Gennari; PierFranco Conte; Riccardo Rosso; Cinzia Orlandini; Paolo Br 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 1 views

The impact of tumor progesterone recepto

The impact of tumor progesterone receptor status on optimal adjuvant endocrine therapy for postmenopausal patients with early-stage breast cancer : A decision analysis

✍ Rinaa S. Punglia; Karen M. Kuntz; Eric P. Winer; Jane C. Weeks; Harold J. Burste 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 354 KB 👁 1 views

Anastrozole versus megestrol acetate in

Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma : Results of a survival update based on a combined analysis of data from two mature phase III trials

✍ Aman U. Buzdar; Walter Jonat; Anthony Howell; Stephen E. Jones; Carl P. Blomqvis 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 2 views

Medical University of BACKGROUND. This report presents the results of a survival update based on the combined data from two studies that compared the efficacy and tolerability of anastrozole (1 or 10 mg once daily), a selective, nonsteroidal aromatase inhibitor administered orally, and megestrol ace